BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 20827105)

  • 41. Molecular characteristics of methicillin-resistant Staphylococcus aureus blood isolates: clonal spread of staphylococcal cassette chromosome mec type IVA between the community and the hospital.
    Moon SY; Lee HJ; Lee MS
    Microb Drug Resist; 2010 Sep; 16(3):217-22. PubMed ID: 20735176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia.
    Jokinen E; Lindholm L; Huttunen R; Huhtala H; Vuento R; Vuopio J; Syrjänen J
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):937-943. PubMed ID: 29428976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome.
    Lin JC; Yeh KM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Feb; 37(1):24-8. PubMed ID: 15060683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia.
    Abraham J; Mansour C; Veledar E; Khan B; Lerakis S
    Am Heart J; 2004 Mar; 147(3):536-9. PubMed ID: 14999206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and characterisation of Staphylococcus aureus causing community-acquired skin and soft tissue infections on Java and Bali, Indonesia.
    Santosaningsih D; Santoso S; Setijowati N; Rasyid HA; Budayanti NS; Suata K; Widhyatmoko DB; Purwono PB; Kuntaman K; Damayanti D; Prakoeswa CRS; Laurens M; van Nierop JWI; Nanninga GL; Oudenes N; de Regt M; Snijders SV; Verbrugh HA; Severin JA
    Trop Med Int Health; 2018 Jan; 23(1):34-44. PubMed ID: 29124834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
    Li Z; Zhuang H; Wang G; Wang H; Dong Y
    BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Next-Generation Sequence Analysis Reveals Transfer of Methicillin Resistance to a Methicillin-Susceptible Staphylococcus aureus Strain That Subsequently Caused a Methicillin-Resistant Staphylococcus aureus Outbreak: a Descriptive Study.
    Weterings V; Bosch T; Witteveen S; Landman F; Schouls L; Kluytmans J
    J Clin Microbiol; 2017 Sep; 55(9):2808-2816. PubMed ID: 28679522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
    Wolkewitz M; Frank U; Philips G; Schumacher M; Davey P;
    J Antimicrob Chemother; 2011 Feb; 66(2):381-6. PubMed ID: 21098543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection.
    Porto JP; Santos RO; Gontijo Filho PP; Ribas RM
    Rev Soc Bras Med Trop; 2013; 46(6):713-8. PubMed ID: 24474012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences.
    Jiménez JN; Ocampo AM; Vanegas JM; Rodriguez EA; Mediavilla JR; Chen L; Muskus CE; Vélez LA; Rojas C; Restrepo AV; Garcés C; Kreiswirth BN; Correa MM
    Int J Med Microbiol; 2013 Mar; 303(2):76-83. PubMed ID: 23369303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.
    Naves KS; Vaz da Trindade N; Gontijo Filho PP
    Rev Soc Bras Med Trop; 2012; 45(2):189-93. PubMed ID: 22534990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.
    Joo EJ; Park DA; Kang CI; Chung DR; Song JH; Lee SM; Peck KR
    Korean J Intern Med; 2019 Nov; 34(6):1347-1362. PubMed ID: 29347812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
    Brown J; Paladino JA
    Pharmacoeconomics; 2010; 28(7):567-75. PubMed ID: 20550222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality.
    de Oliveira Conterno L; Wey SB; Castelo A
    Braz J Infect Dis; 2002 Dec; 6(6):288-97. PubMed ID: 12585972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.
    Wang FD; Chen YY; Chen TL; Liu CY
    Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial susceptibility and molecular characteristics of 857 methicillin-resistant Staphylococcus aureus isolates from 16 medical centers in Japan (2008-2009): nationwide survey of community-acquired and nosocomial MRSA.
    Yanagihara K; Araki N; Watanabe S; Kinebuchi T; Kaku M; Maesaki S; Yamaguchi K; Matsumoto T; Mikamo H; Takesue Y; Kadota J; Fujita J; Iwatsuki K; Hino H; Kaneko T; Asagoe K; Ikeda M; Yasuoka A; Kohno S
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):253-7. PubMed ID: 22244779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular analysis and susceptibility patterns of methicillin-resistant Staphylococcus aureus strains causing community- and health care-associated infections in the northern region of Palestine.
    Adwan K; Jarrar N; Abu-Hijleh A; Adwan G; Awwad E; Salameh Y
    Am J Infect Control; 2013 Mar; 41(3):195-8. PubMed ID: 22998783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.